You Position: Home > Paper

Prevention, Monitor and management of HBV drug-resistance

( views:183, downloads:0 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
Issue:
1
DOI:
10.3760/cma.j.issn.1674-2397.2008.01.004
Key Word:
No keyword available

Abstract: @@ HBV耐药是一个严峻的问题:(1)多数慢性乙型肝炎患者需长期接受抗病毒治疗.在慢性乙型肝炎患者中,HBeAg(-)患者约占40%,他们均需长期治疗;HBeAg(+)患者约占60%,其中20%的患者于治疗1年后可发生HBeAg转阴或转换,但80%的患者于治疗1年时HBeAg并不转换,他们需要长期抗病毒治疗.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn